TY - JOUR
T1 - Definitions and outcome measures for mucous membrane pemphigoid
T2 - Recommendations of an international panel of experts
AU - Murrell, Dedee F.
AU - Marinovic, Branka
AU - Caux, Frederic
AU - Prost, Catherine
AU - Ahmed, Razzaque
AU - Wozniak, Katarzyna
AU - Amagai, Masayuki
AU - Bauer, Johann
AU - Beissert, Stefan
AU - Borradori, Luca
AU - Culton, Donna
AU - Fairley, Janet A.
AU - Fivenson, David
AU - Jonkman, Marcel F.
AU - Marinkovich, M. Peter
AU - Woodley, David
AU - Zone, John
AU - Aoki, Valeria
AU - Bernard, Philippe
AU - Bruckner-Tuderman, Leen
AU - Cianchini, Giuseppe
AU - Venning, Vanessa
AU - Diaz, Luis
AU - Eming, Rudiger
AU - Grando, Sergei A.
AU - Hall, Russell P.
AU - Hashimoto, Takashi
AU - Herrero-González, Josep E.
AU - Hertl, Michael
AU - Joly, Pascal
AU - Karpati, Sarolta
AU - Kim, Jaehwan
AU - Chan Kim, Soo
AU - Korman, Neil J.
AU - Kowalewski, Cezary
AU - Lee, Sang Eun
AU - Rubenstein, David R.
AU - Sprecher, Eli
AU - Yancey, Kim
AU - Zambruno, Giovann
AU - Zillikens, Detlef
AU - Doan, Serge
AU - Daniel, Benjamin S.
AU - Werth, Victoria P.
N1 - Funding Information:
The International Pemphigus and Pemphigoid Foundation generously supported hiring rooms at the Annual Meetings of the American Academy of Dermatology and European Academy of Dermatology and Venereology as well as audiovisual equipment and open access. The Korean World Congress Committee and the Society for Investigative Dermatology provided meeting rooms. This material is based on work supported by the Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development) and by the National Institutes of Health ( NIH K24-AR 02207 ) to Dr Werth.
Publisher Copyright:
© 2014 American Academy of Dermatology, Inc.
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Mucous membrane pemphigoid encompasses a group of autoimmune bullous diseases with a similar phenotype characterized by subepithelial blisters, erosions, and scarring of mucous membranes, skin, or both. Although knowledge about autoimmune bullous disease is increasing, there is often a lack of clear definitions of disease, outcome measures, and therapeutic end points. With clearer definitions and outcome measures, it is possible to directly compare the results and data from various studies using meta-analyses. This consensus statement provides accurate and reproducible definitions for disease extent, activity, outcome measures, end points, and therapeutic response for mucous membrane pemphigoid and proposes a disease extent score, the Mucous Membrane Pemphigoid Disease Area Index.
AB - Mucous membrane pemphigoid encompasses a group of autoimmune bullous diseases with a similar phenotype characterized by subepithelial blisters, erosions, and scarring of mucous membranes, skin, or both. Although knowledge about autoimmune bullous disease is increasing, there is often a lack of clear definitions of disease, outcome measures, and therapeutic end points. With clearer definitions and outcome measures, it is possible to directly compare the results and data from various studies using meta-analyses. This consensus statement provides accurate and reproducible definitions for disease extent, activity, outcome measures, end points, and therapeutic response for mucous membrane pemphigoid and proposes a disease extent score, the Mucous Membrane Pemphigoid Disease Area Index.
UR - http://www.scopus.com/inward/record.url?scp=84917671759&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84917671759&partnerID=8YFLogxK
U2 - 10.1016/j.jaad.2014.08.024
DO - 10.1016/j.jaad.2014.08.024
M3 - Review article
C2 - 25443626
AN - SCOPUS:84917671759
SN - 0190-9622
VL - 72
SP - 168
EP - 174
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
IS - 1
ER -